Latest Breaking News On - Tetravalent dengue vaccine - Page 2 : vimarsana.com

Health Ministry studies dengue vaccination - Indonesia Tribune

Health Ministry studies dengue vaccination - Indonesia Tribune
indonesiatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indonesiatribune.com Daily Mail and Mail on Sunday newspapers.

East kalimantanKalimantan timurImran pambudiDrug supervisory agencyMinistry of healthAntara news agencyNational foodTetravalent dengue vaccineCommunicable disease preventionAntara news

Health Ministry studies dengue vaccination

The Ministry of Health is studying the provision of the dengue vaccine, known as the Tetravalent Dengue Vaccine (TDV), as a national vaccination .

East kalimantanKalimantan timurImran pambudiMinistry of healthNational foodDrug supervisory agencyTetravalent dengue vaccineCommunicable disease prevention

Takeda s QDENGA▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

08.12.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in .

Sri lankaUnited statesDominican republicTakeda yakuhin kogyoTomas jelinekWorld health organizationBerlin centre forData monitoring committeeExchange commissionEuropean union eu member statesTakeda pharmaceutical company limitedEuropean centre for disease preventionMedical directorBerlin centreTropical medicineScientific director

Takeda Pharmaceutical Company Limited: Takeda s QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous

Sri lankaUnited statesDominican republicGary dubinRachel higginsTomas jelinekJun saitoEuropean commissionWorld health organizationInternational mediaBerlin centre forData monitoring committeeExchange commissionEuropean commission approvedEuropean union eu member statesEuropean union

Takeda s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U S Food and Drug Administration

OSAKA, Japan and CAMBRIDGE, Massachusetts - Takeda announced that the U.S. Food and Drug Administration has accepted and granted priority review of the Biologics License Application for TAK-003,. | November 23, 2022

American samoaUnited statesSri lankaPuerto ricoDominican republicUnited kingdomGary dubinRachel higginsJun saitoCenters for diseaseWorld health organizationTraveler healthDrug administrationInternational mediaData monitoring committeeExchange commission